Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was to assess the risk of thrombosis and bleeding in patients with CLL affected by severe COVID-19.

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL / Antic, Darko; Milic, Natasa; Chatzikonstantinou, Thomas; Scarfò, Lydia; Otasevic, Vladimir; Rajovic, Nina; Allsup, David; Alonso Cabrero, Alejandro; Andres, Martin; Baile Gonzales, Monica; Capasso, Antonella; Collado, Rosa; Cordoba, Raul; Cuéllar-García, Carolina; Correa, Juan Gonzalo; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Dimou, Maria; Doubek, Michael; Efstathopoulou, Maria; El-Ashwah, Shaimaa; Enrico, Alicia; Espinet, Blanca; Farina, Lucia; Ferrari, Angela; Foglietta, Myriam; Lopez-Garcia, Alberto; García-Marco, José A; García-Serra, Rocío; Gentile, Massimo; Gimeno, Eva; da Silva, Maria Gomes; Gutwein, Odit; Hakobyan, Yervand K; Herishanu, Yair; Hernández-Rivas, José Ángel; Herold, Tobias; Itchaki, Gilad; Jaksic, Ozren; Janssens, Ann; Kalashnikova, Olga B; Kalicińska, Elżbieta; Kater, Arnon P; Kersting, Sabina; Koren-Michowitz, Maya; Labrador, Jorge; Lad, Deepesh; Laurenti, Luca; Fresa, Alberto; Levin, Mark-David; Mayor Bastida, Carlota; Malerba, Lara; Marasca, Roberto; Marchetti, Monia; Marquet, Juan; Mihaljevic, Biljana; Milosevic, Ivana; Mirás, Fatima; Morawska, Marta; Motta, Marina; Munir, Talha; Murru, Roberta; Nunes, Raquel; Olivieri, Jacopo; Pavlovsky, Miguel Arturo; Piskunova, Inga; Popov, Viola Maria; Quaglia, Francesca Maria; Quaresmini, Giulia; Reda, Gianluigi; Rigolin, Gian Matteo; Shrestha, Amit; Šimkovič, Martin; Smirnova, Svetlana; Špaček, Martin; Sportoletti, Paolo; Stanca, Oana; Stavroyianni, Niki; Te Raa, Doreen; Tomic, Kristina; Tonino, Sanne; Trentin, Livio; Van Der Spek, Ellen; van Gelder, Michel; Varettoni, Marzia; Visentin, Andrea; Vitale, Candida; Vukovic, Vojin; Wasik-Szczepanek, Ewa; Wróbel, Tomasz; Segundo, Lucrecia Yáñez San; Yassin, Mohamed; Coscia, Marta; Rambaldi, Alessandro; Montserrat, Emili; Foà, Robin; Cuneo, Antonio; Carrier, Marc; Ghia, Paolo; Stamatopoulos, Kostas. - In: JOURNAL OF HEMATOLOGY & ONCOLOGY. - ISSN 1756-8722. - 15:1(2022). [10.1186/s13045-022-01333-0]

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

Capasso, Antonella;Ghia, Paolo
;
2022-01-01

Abstract

Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immune deficiency. The aim of this study was to assess the risk of thrombosis and bleeding in patients with CLL affected by severe COVID-19.
2022
Age
Anticoagulation therapy
Bleeding
CLL
COVID-19
D-dimer
LMWH
Thromboprophylaxis
Thrombosis
Aged
Anticoagulants
COVID-19 Testing
Hemorrhage
Heparin, Low-Molecular-Weight
Humans
SARS-CoV-2
COVID-19
Leukemia, Lymphocytic, Chronic, B-Cell
Thrombosis
Venous Thromboembolism
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/133451
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact